Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity
Tyler B. Waltz, … , Bin Pan, Cheryl L. Stucky
Tyler B. Waltz, … , Bin Pan, Cheryl L. Stucky
Published April 22, 2024
Citation Information: JCI Insight. 2024;9(8):e172869. https://doi.org/10.1172/jci.insight.172869.
View: Text | PDF
Research Article Neuroscience

Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity

  • Text
  • PDF
Abstract

Patients with Fabry disease suffer from chronic debilitating pain and peripheral sensory neuropathy with minimal treatment options, but the cellular drivers of this pain are unknown. Here, we propose a mechanism we believe to be novel in which altered signaling between Schwann cells and sensory neurons underlies the peripheral sensory nerve dysfunction we observed in a genetic rat model of Fabry disease. Using in vivo and in vitro electrophysiological recordings, we demonstrated that Fabry rat sensory neurons exhibited pronounced hyperexcitability. Schwann cells probably contributed to this finding because application of mediators released from cultured Fabry Schwann cells induced spontaneous activity and hyperexcitability in naive sensory neurons. We examined putative algogenic mediators using proteomic analysis and found that Fabry Schwann cells released elevated levels of the protein p11 (S100A10), which induced sensory neuron hyperexcitability. Removal of p11 from Fabry Schwann cell media caused hyperpolarization of neuronal resting membrane potentials, indicating that p11 may contribute to the excessive neuronal excitability caused by Fabry Schwann cells. These findings demonstrate that sensory neurons from rats with Fabry disease exhibit hyperactivity caused in part by Schwann cell release of the protein p11.

Authors

Tyler B. Waltz, Dongman Chao, Eve K. Prodoehl, Jonathan D. Enders, Vanessa L. Ehlers, Bhavya S. Dharanikota, Nancy M. Dahms, Elena Isaeva, Quinn H. Hogan, Bin Pan, Cheryl L. Stucky

×

Figure 2

Isolated small-diameter DRG neurons isolated from Fabry rats exhibit spontaneous activity and current-evoked hyperexcitability.

Options: View larger image (or click on image) Download as PowerPoint
Isolated small-diameter DRG neurons isolated from Fabry rats exhibit spo...
(A) A higher proportion of isolated Fabry DRG neuron somata exhibit spontaneous activity compared with WT. (B) Minimal action potential current threshold (rheobase) of Fabry neurons is reduced compared with WT neurons. (C) Current protocol for determining current-evoked firing frequency of Fabry and WT neurons with representative traces of Fabry and WT neurons undergoing current stimulation of 200 pA above rheobase for 500 ms. (D) Fabry DRG neurons exhibit increased firing frequency due to suprathreshold current stimulation. (A) n = 33–34 neurons from 6 animals per genotype; (B–D) n = 37–38 neurons from 8 animals per genotype. Data for A reported as mean, B and D as mean ± SEM. (A) χ2 Fisher’s exact post hoc comparison, (B) unpaired Student’s t test, (D) 2-way repeated measures ANOVA significant main effect of treatment, Bonferroni post hoc comparison. * P < 0.05. AP, action potential.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts